
#' Anti-hypertensive trial clinical endpoint data
#' 
#' AHT trial data set: Randomized, placebo controlled, Double-blind, parallel study;    								
#'Subjects randomized to Placebo and AHT in the ratio 1:1; Dose of AHT studied : 5mg									
#'Primary endpoint: Change from baseline blood pressure (systolic and diastolic) measured at 8 weeks.									
#'Details of the Data Column: ID=Subject ID, Age: Age(years), Weight : Weight(Kg), SCreatinine: Serum Creatinine(mg/dl), 
#'SerumALT: Serum Alanine aminotransferase(IU/L), DelDBP: Change from baseline diastolic blood pressure(mm Hg), 
#'DELSBP: Change from baseline systolic blood pressure (mm Hg), TRT: Treatment, Dose: Dose (microgram,Âµg)									

#' 
#' \itemize{
#'   \item ID. Numerical ID  (1--100)
#'   \item AGE. Age in Years 
#'   \item WEIGHT Weight in Kg
#'   \item SCREATININE. Serum creatinine in mg/dl
#'   \item SERUMALT. Serum Alanine Aminotransferase  in IU/L
#'   \item GENDER. Male or Female gender identification
#'   \item RACE. Ethnicity
#'   \item DELDBP. Change from baseline in Diastolic blood pressure, mmHg 
#'   \item DELSBP. Change from baseline in Systolic blood pressure, mmHg 
#'   \item TRT. Treatment indicator: Placebo and AHT group 
#'   \item DOSE. Dose of AHT in ug 
#' }
#' 
#' @docType data
#' @keywords datasets
#' @name aht_trial2
#' @usage data(aht_trial2)
#' @format A data frame with 100 rows and 11 variables
NULL




								
